AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2019
Jul 12, 2019
32163_dirs_2019-07-12_a2cf6e58-cbc9-4c28-8c3c-c43ca36a5d2f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2019-07-10
Reporting Person: Dreyer Scott (EVP & Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-10 | Common Stock | F | 1190 | $12.44 | Disposed | 40596 | Direct |
| 2019-07-11 | Common Stock | S | 2857 | $12.31 | Disposed | 37739 | Direct |
Footnotes
F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Annual Report
2026
Feb 26